frovatriptan succinate

frovatriptan succinate (FROVATRIPTAN SUCCINATE) is an FDA-listed pharmaceutical active ingredient. Associated with Amneal Pharma Europe Ltd. Route of administration: oral. Current US regulatory status: approved.

FROVATRIPTAN SUCCINATE is a marketed brand name for frovatriptan succinate. Check FDA Drugs@FDA for the current US label holder and prescribing information.

frovatriptan succinate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.